We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Top Sells

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$180M
2
PXD
Pioneer Natural Resource Co.
PXD
+$121M
3
GE icon
GE Aerospace
GE
+$59.1M
4
UNH icon
UnitedHealth
UNH
+$46.6M
5
NVDA icon
NVIDIA
NVDA
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INMB icon
3201
INmune Bio
INMB
$55.3M
$121K ﹤0.01%
+13,773
New +$136K
INFU icon
3202
InfuSystem Holdings
INFU
$249M
$121K ﹤0.01%
17,658
+2,145
+14% +$15.8K
EBS icon
3203
Emergent Biosolutions
EBS
$248M
$120K ﹤0.01%
17,624
-69,920
-80% -$301K
OPRA
3204
Opera Ltd
OPRA
$1.79B
$119K ﹤0.01%
8,463
-317
-4% -$4.5K
LUNR icon
3205
Intuitive Machines
LUNR
$2.63B
$119K ﹤0.01%
+35,974
New +$179K
CTNM
3206
Contineum Therapeutics
CTNM
$566M
$118K ﹤0.01%
+6,722
New +$108K
DQ
3207
Daqo New Energy
DQ
$996M
$118K ﹤0.01%
8,104
+1,470
+22% +$30.9K
ICL icon
3208
ICL Group
ICL
$6.85B
$118K ﹤0.01%
27,475
+900
+3% +$4.24K
GLSI icon
3209
Greenwich LifeSciences
GLSI
$211M
$117K ﹤0.01%
+6,799
New +$99.3K
RCI icon
3210
Rogers Communications
RCI
$18.6B
$117K ﹤0.01%
3,169
– –
ASPI icon
3211
ASP Isotopes
ASPI
$558M
$116K ﹤0.01%
+38,056
New +$147K
GTHX
3212
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$115K ﹤0.01%
50,632
+49,665
+5,136% +$190K
SU icon
3213
Suncor Energy
SU
$70.3B
$115K ﹤0.01%
3,021
-529
-15% -$20.4K
FBLG icon
3214
FibroBiologics
FBLG
$6.5M
$115K ﹤0.01%
+1,153
New +$220K
B
3215
Barrick Mining
B
$73.2B
$115K ﹤0.01%
6,894
-2,716
-28% -$46.1K
YMM icon
3216
Full Truck Alliance
YMM
$9.99B
$115K ﹤0.01%
14,269
-27,048
-65% -$230K
OEF icon
3217
iShares S&P 100 ETF
OEF
$20.6B
$114K ﹤0.01%
433
+200
+86% +$50.1K
NTIC icon
3218
Northern Technologies International Corp
NTIC
$80M
$114K ﹤0.01%
+6,891
New +$115K
LKFT
3219
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
$113K ﹤0.01%
4,578
+814
+22% +$23.1K
ALIM
3220
DELISTED
Alimera Sciences
ALIM
$113K ﹤0.01%
+20,394
New +$72.4K
LTM
3221
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$113K ﹤0.01%
251,901
+3,931
+2% +$1.77K
MOND
3222
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$113K ﹤0.01%
47,225
-842
-2% -$1.88K
LCUT icon
3223
Lifetime Brands
LCUT
$210M
$113K ﹤0.01%
13,173
+11,233
+579% +$113K
DIBS icon
3224
1stdibs.com
DIBS
$171M
$113K ﹤0.01%
25,201
+24,835
+6,786% +$136K
ANRO icon
3225
Alto Neuroscience
ANRO
$1.11B
$113K ﹤0.01%
+10,539
New +$137K
127 128
129
130 131

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.